• Phone
  • Contact us
  • Locations
  • Search
  • Menu
  • Add this article to your LinkedIn page
  • Add this article to your Twitter feed
  • Email this article
.

life sciences

We provide a distinctive combination of management and technology consultancy. We’re innovative and pragmatic. We work with a range of teams: research and development, quality and regulatory, technical and commercial operations as well as marketing and sales. 

We can help you:

  • unlock scientific and technology advances for competitive advantage in pharma, biotech or medical devices
  • develop new products and services
  • meet patients’ demand for better healthcare, treatments and medicines
  • make the most of digital’s potential for creating more integrated healthcare products and services
  • ensure quality and regulatory compliance
  • transform data  into customer intelligence
  • improve performance and cost efficiency for greater productivity.

We combine sector insight with specialist expertise drawn from different geographies and disciplines. And we can manage change addressing the cultural, organisational, people and technological impacts.

 
 

Latest insights
and client stories

PA opinion

  • Brexit: the eye of the stormThe UK life sciences sector will undoubtedly be affected by the Brexit after the decision that Article 50 will be triggered by the end of March 2017; and it needs to start preparing now for the uncertainties ahead. 19/10/2016
  • Insights from the 2016 Exponential Medicine conferenceThe Exponential Medicine conference brings together physicians, innovators, and inventors to explore fast-moving technologies disrupting healthcare. 12/10/2016
  • Gaining competitive advantage in medical devicesGaining competitive advantage in medical devices - how to optimise time- and cost-to-market in product development 16/09/2016
  • The risks of Brexit for the UK's clinical development services It is clear that Brexit presents challenges to many companies in the UK life sciences sector and they will need to make their voices heard as negotiations begin about the exact terms of the exit from the EU. 31/08/2016
  • Building trust in rare and orphan diseasesBy 2020, the market for rare and orphan disease treatments is estimated to grow to $178 billion – amounting to 20% of the total prescription drug sales. As a result, pharma companies are increasingly seeking to shift from the traditional role of a supplier of medicines to become a more active, patient-centric partner in healthcare. 28/06/2016
  • Achieving cost-out maturityLearn how leading organisations cross-industry take costs out of their businesses to drive substantial savings 03/05/2016
  • Driving sustainable innovation in manufacturingManufacturers are spending more on innovation but our research shows half of the ideas they generate fail to become a reality. So how can they ensure their innovative ideas turn into commercial success? 07/06/2016
  • Mining care pathways to drive innovation and valueUnderstanding care pathways provide a series of new perspectives and insights to address many of the issues challenging pharmaceutical companies. 22/04/2016
  • Digitising agricultureHow organisations can unlock the potential in the agricultural value chain 10/12/2015
  • New technology opportunitiesWhat is hype and where is the opportunity? We surveyed business leaders across a range of sectors to understand the technologies that really drive value. 03/12/2015
  • The Age of Disruption - insights from the 2015 European Process Excellence conferenceDrawing on insights presented at the 2015 European Process Excellence conference, PA's new report delves into the main messages from the event and elaborates on key learnings from the presenters which included Dr Iris Kaib, VP at Deutsche Post, Simon Tompsett, Head of Change at Airbus and Erik Gillet, Global Process Excellence Leader at UBS among many others. 21/08/2015
  • 2015 UK IT Outsourcing Study ResultsThe results are in from the 2015 UK IT Outsourcing Study, conducted by Whitelane Research in collaboration with PA Consulting Group. The study, that covers all industry sectors, investigates more than 800 unique IT outsourcing contracts held by over 260 of the top IT spending organisations across the UK. 09/06/2015

Client story

PA in the media

Contact

Find out more about our work in life sciences.

Contact the life sciences team

Andrew Hooke

Andrew Hooke

Email

Connect

Sören Knudsen

Sören Knudsen

Email

Connect

Alexander Tamdjidi

Alexander Tamdjidi

Email

Connect

Milind Kamkolkar

Milind Kamkolkar

Email

Connect

Natalia Misciattelli

Natalia Misciattelli

Email

Connect

By using this website, you accept the use of cookies. For more information on how to manage cookies, please read our privacy policy.

×